Literature DB >> 33849399

A health crisis within a health crisis: Opioid access in the COVID-19 pandemic.

Aditya Narayan1, Rajesh Balkrishnan1.   

Abstract

The novel coronavirus has thrown large sections of our healthcare system into disarray, with providers overburdened by record breaking number of hospitalizations and deaths. The U.S., in particular, has remained the nation with one of the fastest growing case counts in the world. As a consequence, many other critical healthcare needs have not received the necessary resources or consideration. This commentary draws attention to substance use and opioid access during the ongoing crisis, given the potential for breakdowns in treatment access for addiction, the growing concern of mental health comorbidities, and the lack of access for those who require opioids for adequate pain management. Further, the commentary will offer policy and practice recommendations that may be implemented to provide more equitable distribution of care.

Entities:  

Keywords:  COVID-19; Opioid; buprenorphine; coronavirus; methadone; opiate substitution treatment; pain management; social isolation

Year:  2021        PMID: 33849399     DOI: 10.1080/08897077.2021.1900981

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  1 in total

1.  COVID-19 economic impact payments and opioid overdose deaths.

Authors:  Jon E Sprague; Arthur B Yeh; Qizhen Lan; Jamie Vieson; Maggie McCorkle
Journal:  Int J Drug Policy       Date:  2022-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.